{"id":"https://openalex.org/W2016015039","doi":"https://doi.org/10.2174/1568008053174723","title":"CXCR3-binding Chemokines: Novel Multifunctional Therapeutic Targets","display_name":"CXCR3-binding Chemokines: Novel Multifunctional Therapeutic Targets","publication_year":2005,"publication_date":"2005-03-01","ids":{"openalex":"https://openalex.org/W2016015039","doi":"https://doi.org/10.2174/1568008053174723","mag":"2016015039","pmid":"https://pubmed.ncbi.nlm.nih.gov/15777209"},"language":"en","primary_location":{"id":"doi:10.2174/1568008053174723","doi":"https://doi.org/10.2174/1568008053174723","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1568008053174723","pdf_url":null,"source":{"id":"https://openalex.org/S118480599","display_name":"Current Drug Targets - Immune Endocrine & Metabolic Disorders","issn_l":"1568-0088","issn":["1568-0088","1875-5917"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Drug Targets - Immune, Endocrine &amp; Metabolic Disorders","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://flore.unifi.it/bitstream/2158/1190747/1/lazzeri2005.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049297489","display_name":"Elena Lazzeri","orcid":"https://orcid.org/0000-0002-9505-2115","observed_orcids":["https://orcid.org/0000-0002-9505-2115"]},"institutions":[{"id":"https://openalex.org/I45084792","display_name":"University of Florence","ror":"https://ror.org/04jr1s763","country_code":"IT","type":"education","lineage":["https://openalex.org/I45084792"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"E. Lazzeri","raw_affiliation_strings":["Department of Clinical Pathophysiology, University of Florence, Viale Pieraccini 6, 50139-Florence, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pathophysiology, University of Florence, Viale Pieraccini 6, 50139-Florence, Italy","institution_ids":["https://openalex.org/I45084792"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5046254027","display_name":"Paola Romagnani","orcid":"https://orcid.org/0000-0002-1774-8088","observed_orcids":["https://orcid.org/0000-0002-1774-8088"]},"institutions":[{"id":"https://openalex.org/I45084792","display_name":"University of Florence","ror":"https://ror.org/04jr1s763","country_code":"IT","type":"education","lineage":["https://openalex.org/I45084792"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"P. Romagnani","raw_affiliation_strings":["Department of Clinical Pathophysiology, University of Florence, Viale Pieraccini 6, 50139-Firenze, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pathophysiology, University of Florence, Viale Pieraccini 6, 50139-Firenze, Italy","institution_ids":["https://openalex.org/I45084792"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5046254027"],"corresponding_institution_ids":["https://openalex.org/I45084792"],"apc_list":null,"apc_paid":null,"fwci":5.5802,"has_fulltext":true,"cited_by_count":110,"citation_normalized_percentile":{"value":0.96817764,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"5","issue":"1","first_page":"109","last_page":"118"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11532","display_name":"Chemokine receptors and signaling","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11532","display_name":"Chemokine receptors and signaling","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13223","display_name":"Connective Tissue Growth Factor Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14165","display_name":"Inflammation biomarkers and pathways","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cxcr3","display_name":"CXCR3","score":0.9670000076293945},{"id":"https://openalex.org/keywords/cxcl9","display_name":"CXCL9","score":0.7919999957084656},{"id":"https://openalex.org/keywords/cxcl10","display_name":"CXCL10","score":0.9980000257492065},{"id":"https://openalex.org/keywords/chemokines","display_name":"chemokines","score":0.8389999866485596},{"id":"https://openalex.org/keywords/angiostasis","display_name":"angiostasis","score":0.7590000033378601},{"id":"https://openalex.org/keywords/leukocyte-recruitment","display_name":"leukocyte recruitment","score":0.6840000152587891},{"id":"https://openalex.org/keywords/anti-tumor-effect","display_name":"anti-tumor effect","score":0.7099999785423279},{"id":"https://openalex.org/keywords/allograft-rejection","display_name":"allograft rejection","score":0.8980000019073486},{"id":"https://openalex.org/keywords/glomerulonephritis","display_name":"glomerulonephritis","score":0.8899999856948853},{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.7459999918937683},{"id":"https://openalex.org/keywords/autoimmune-thyroid-disease","display_name":"autoimmune thyroid disease","score":0.8309999704360962},{"id":"https://openalex.org/keywords/cxcr3-antagonist","display_name":"CXCR3 antagonist","score":0.6399999856948853},{"id":"https://openalex.org/keywords/oral-small-molecule","display_name":"oral small molecule","score":0.4490000009536743}],"concepts":[{"id":"https://openalex.org/C25532541","wikidata":"https://www.wikidata.org/wiki/Q655541","display_name":"CXCR3","level":5,"score":0.8215816617012024},{"id":"https://openalex.org/C17502307","wikidata":"https://www.wikidata.org/wiki/Q411999","display_name":"CXCL9","level":5,"score":0.6932610273361206},{"id":"https://openalex.org/C13425408","wikidata":"https://www.wikidata.org/wiki/Q5014882","display_name":"CXCL11","level":5,"score":0.6326701045036316},{"id":"https://openalex.org/C12823836","wikidata":"https://www.wikidata.org/wiki/Q24720618","display_name":"Chemokine receptor","level":4,"score":0.6119897365570068},{"id":"https://openalex.org/C5858377","wikidata":"https://www.wikidata.org/wiki/Q986112","display_name":"CXCL10","level":4,"score":0.5727782845497131},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.524696946144104},{"id":"https://openalex.org/C13373296","wikidata":"https://www.wikidata.org/wiki/Q421866","display_name":"Chemokine","level":3,"score":0.5074986815452576},{"id":"https://openalex.org/C45635710","wikidata":"https://www.wikidata.org/wiki/Q418404","display_name":"Chemokine receptor CCR5","level":5,"score":0.5003664493560791},{"id":"https://openalex.org/C1423137","wikidata":"https://www.wikidata.org/wiki/Q21113928","display_name":"CCR3","level":5,"score":0.4944489002227783},{"id":"https://openalex.org/C129013479","wikidata":"https://www.wikidata.org/wiki/Q21111916","display_name":"CCR1","level":5,"score":0.47206738591194153},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.46960529685020447},{"id":"https://openalex.org/C82321936","wikidata":"https://www.wikidata.org/wiki/Q14907780","display_name":"CX3CL1","level":5,"score":0.44489988684654236},{"id":"https://openalex.org/C13164669","wikidata":"https://www.wikidata.org/wiki/Q5009628","display_name":"CCL7","level":5,"score":0.43725037574768066},{"id":"https://openalex.org/C54166955","wikidata":"https://www.wikidata.org/wiki/Q658145","display_name":"Chemotaxis","level":3,"score":0.4345752000808716},{"id":"https://openalex.org/C94205230","wikidata":"https://www.wikidata.org/wiki/Q5005868","display_name":"C-C chemokine receptor type 6","level":5,"score":0.4300330579280853},{"id":"https://openalex.org/C29146819","wikidata":"https://www.wikidata.org/wiki/Q21113975","display_name":"CCL13","level":5,"score":0.42822521924972534},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.38819101452827454},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.36837685108184814},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.34848272800445557},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.2826523184776306},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.060966163873672485}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001327","descriptor_name":"Autoimmune Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001327","descriptor_name":"Autoimmune Diseases","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D014184","descriptor_name":"Transplantation, Homologous","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D014184","descriptor_name":"Transplantation, Homologous","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D016503","descriptor_name":"Drug Delivery Systems","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D019707","descriptor_name":"Receptors, Chemokine","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D019707","descriptor_name":"Receptors, Chemokine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D054367","descriptor_name":"Receptors, CXCR3","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.2174/1568008053174723","doi":"https://doi.org/10.2174/1568008053174723","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1568008053174723","pdf_url":null,"source":{"id":"https://openalex.org/S118480599","display_name":"Current Drug Targets - Immune Endocrine & Metabolic Disorders","issn_l":"1568-0088","issn":["1568-0088","1875-5917"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Drug Targets - Immune, Endocrine &amp; Metabolic Disorders","raw_type":"journal-article"},{"id":"pmid:15777209","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15777209","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current drug targets. Immune, endocrine and metabolic disorders","raw_type":"Journal Article"},{"id":"pmh:oai:flore.unifi.it:2158/1190747","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/2158/1190747","pdf_url":"https://flore.unifi.it/bitstream/2158/1190747/1/lazzeri2005.pdf","source":{"id":"https://openalex.org/S4306402033","display_name":"Florence Research (University of Florence)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45084792","host_organization_name":"University of Florence","host_organization_lineage":["https://openalex.org/I45084792"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:flore.unifi.it:2158/1190747","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/2158/1190747","pdf_url":"https://flore.unifi.it/bitstream/2158/1190747/1/lazzeri2005.pdf","source":{"id":"https://openalex.org/S4306402033","display_name":"Florence Research (University of Florence)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45084792","host_organization_name":"University of Florence","host_organization_lineage":["https://openalex.org/I45084792"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320323054","display_name":"Associazione Italiana per la Ricerca sul Cancro","ror":"https://ror.org/02g2x7380"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2016015039.pdf","grobid_xml":"https://content.openalex.org/works/W2016015039.grobid-xml"},"referenced_works_count":1,"referenced_works":["https://openalex.org/W564754985"],"related_works":["https://openalex.org/W2020102380","https://openalex.org/W2088007570","https://openalex.org/W200125766","https://openalex.org/W2982480194","https://openalex.org/W2029824788","https://openalex.org/W7096013313","https://openalex.org/W2041797267","https://openalex.org/W2580133892","https://openalex.org/W2148195060","https://openalex.org/W2169632765"],"abstract_inverted_index":{"The":[0,118],"goal":[1],"to":[2,60,67,179,267],"attenuate":[3],"inflammation":[4],"without":[5],"inducing":[6],"generalized":[7],"immunosuppression":[8],"has":[9,136],"focused":[10],"the":[11,22,28,40,51,58,65,69,116,148,167,180,204,224,228],"attention":[12],"on":[13,156,223,240],"chemokines,":[14],"a":[15,84,140,192],"family":[16],"of":[17,30,71,90,115,151,169,183,207,231,257],"chemotactic":[18],"peptides":[19],"that":[20,32,42,147,200],"regulate":[21],"leukocyte":[23],"traffick":[24],"into":[25],"tissues.":[26],"However,":[27],"development":[29],"drugs":[31],"block":[33],"ckemokine":[34],"activity":[35,206,272],"may":[36],"be":[37,161,268],"hampered":[38],"by":[39,83,166],"observation":[41],"some":[43],"chemokines":[44,52,96,171,233],"display":[45],"pleiotropic":[46,92],"biologic":[47,93],"functions.":[48],"For":[49],"example,":[50],"CXCL9/Mig,":[53],"CXCL10/IP-10,":[54],"and":[55,112,127,154,251],"CXCL11/I-TAC":[56],"exhibit":[57],"ability":[59],"recruit":[61],"different":[62,149,248],"leukocytes":[63],"subsets,":[64],"capacity":[66],"induce":[68],"proliferation":[70],"vascular":[72],"pericytes":[73],"as":[74,76,100,190,213],"well":[75],"powerful":[77],"anti-tumor":[78],"effects,":[79,94,131],"which":[80,186],"are":[81,261],"mediated":[82],"common":[85],"receptor,":[86,185],"named":[87],"CXCR3.":[88],"Because":[89],"their":[91,271],"these":[95,170],"have":[97,188,243],"been":[98],"proposed":[99],"possible":[101],"therapeutic":[102],"targets":[103],"in":[104,177,234,247,265,273],"cancer,":[105],"allograft":[106],"rejection,":[107],"glomerulonephritis,":[108],"diabetes,":[109],"multiple":[110],"sclerosis,":[111],"autoimmune":[113],"disorders":[114],"thyroid.":[117],"chemokine":[119],"CXCL4/PF4":[120],"shares":[121],"several":[122,235],"activities":[123],"with":[124,172],"CXCL9,":[125,152],"CXCL10,":[126,153],"CXCL11,":[128],"including":[129],"angiostatic":[130,205],"although":[132],"its":[133,245],"specific":[134],"receptor":[135,195,215,260],"remained":[137],"unknown":[138],"for":[139,216,270],"long":[141],"time.":[142],"Recently,":[143],"we":[144,187,221],"provided":[145],"evidence":[146,226],"functions":[150],"CXCL11":[155],"distinct":[157,174],"cell":[158],"types":[159],"can":[160],"at":[162],"least":[163],"partly":[164],"explained":[165],"interaction":[168],"two":[173],"receptors.":[175],"Indeed,":[176],"addition":[178],"classic":[181],"form":[182],"CXCR3":[184,194,208,241],"renamed":[189],"CXCR3-A,":[191],"novel":[193],"variant":[196],"(CXCR3-B)":[197],"was":[198],"identified,":[199],"not":[201],"only":[202],"mediates":[203],"ligands,":[209],"but":[210],"also":[211],"acts":[212],"functional":[214],"CXCL4.":[217],"In":[218],"this":[219,259],"review,":[220],"focus":[222],"accumulating":[225],"demonstrating":[227],"pivotal":[229],"role":[230],"CXCR3-binding":[232],"human":[236],"diseases.":[237],"Studies":[238],"based":[239],"targeting":[242],"shown":[244],"importance":[246],"pathologic":[249],"conditions":[250],"orally":[252],"active":[253],"small":[254],"molecules":[255],"capable":[256],"inhibiting":[258],"now":[262],"being":[263],"developed":[264],"order":[266],"tested":[269],"humans.":[274]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}
